Influenza A virus A/California/7/2009 (H1N1)-like antigen (propiolactone inactivated)

DB14444ApprovedInvestigationalWithdrawnVaccines

A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen".

First approval
United States, 2009
Also known as
Influenza a Virus A/california/7/2009(h1n1)-like Antigen (Propiolactone Inactivated)

What you can answer from here — as of April 02, 2025

38Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Marketed productsAcross 1 country and 1 labeller
Sign in

Which companies are running trials of Influenza A virus A/California/7/2009 (H1N1)-like antigen (propiolactone inactivated), in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account